Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms
about
A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathyImportance of the release of strand 1C to the polymerization mechanism of inhibitory serpinsLatent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodiesDependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer.A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerizationPolymerization of plasminogen activator inhibitor-1.Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System.Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopyThe human serpin proteinase inhibitor-9 self-associates at physiological temperatures.Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic diseaseThe CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity.The plasmin-antiplasmin system: structural and functional aspects.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Biophysical Mechanisms Mediating Fibrin Fiber Lysis.Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01.The biostructural pathology of the serpins: critical function of sheet opening mechanism.Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.Recombinant protein production using the Semliki Forest Virus expression systemReduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors.PCR-RFLP detection of PAI-2 variants in myocardial infarction.alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization.Pathogenic α1-Antitrypsin Polymers Are Formed by Reactive Loop-β-Sheet A Linkage
P2860
Q24564566-C02DE604-5D59-4EEA-AEF8-D30CC32DAD54Q24673786-E70172B1-602F-4522-A284-0995EEDAD81BQ28303740-5A2FB4CA-EE07-4025-B381-6F9B717FBC7AQ30502082-25A7B9B4-0638-42B5-BEDE-93BB2BE6D937Q31137762-D6FDEFE4-C3D1-474F-B5F3-47715670AAB5Q31645732-54A82422-E1BF-4BFC-8F2E-2EDF52197BE9Q34324817-B9D8F20D-C4EE-45DB-97B3-C0DCEDCC3CEEQ36255413-1D5D5683-65DA-44C3-8368-4380B1A371F0Q36279544-F325F3D9-276E-4635-884E-8BB6C013C460Q36519309-31C3D0EA-3CAA-4B66-9D1E-5C9D570CD1D3Q37089607-E89775FD-FF38-4BC6-B645-52D51934B9BCQ37219827-EAE3A88C-50F1-45DB-84D0-5AB8253BBF48Q37817023-CE20C19C-2621-4BDA-9A8B-7ED8BCFEE203Q38189275-CB53D873-B446-4A15-AC62-B3979CD161D7Q38669149-E6E583D6-00B8-4DF4-A8A7-450711B980DAQ40783138-9370426D-D6A2-4424-A22F-8D32B81371D2Q41224616-40C5CB85-80C2-458D-9907-EA090244DB2FQ42157228-5269DD40-363A-46CD-AAC7-AE82C657AA9EQ42326907-5F59ED11-09DD-4014-BB74-D68C29ADDC1DQ45861101-B23D90D0-DB44-4924-8BD0-27CED67F668CQ47344949-1ED8C23A-836E-4619-B01A-C9E89B3A8698Q49046548-D5AA67D2-C1E7-49D8-AE48-D0CD9306F767Q57980256-9DF6F54B-2183-4475-A132-5DF401CE920E
P2860
Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Plasminogen-activator inhibito ...... llular and extracellular forms
@ast
Plasminogen-activator inhibito ...... llular and extracellular forms
@en
Plasminogen-activator inhibito ...... llular and extracellular forms
@nl
type
label
Plasminogen-activator inhibito ...... llular and extracellular forms
@ast
Plasminogen-activator inhibito ...... llular and extracellular forms
@en
Plasminogen-activator inhibito ...... llular and extracellular forms
@nl
prefLabel
Plasminogen-activator inhibito ...... llular and extracellular forms
@ast
Plasminogen-activator inhibito ...... llular and extracellular forms
@en
Plasminogen-activator inhibito ...... llular and extracellular forms
@nl
P2093
P2860
P1433
P1476
Plasminogen-activator inhibito ...... llular and extracellular forms
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1993.TB18467.X
P407
P577
1993-12-15T00:00:00Z